Account wins from the 06/13/06 News Brief

Share this article:
Noonan Russo has reported the addition of two California biopharmaceutical companies -- Ambrx and Aerovance -- to its client roster.The agency will develop and implement integrated communications programs to raise the companies’ profiles among prospective investors, business partners and employees.  Program activities will consist of message development, key opinion leader outreach, investor identification and targeting, and media relations.Ambrx is a San Diego-based biopharmaceutical company focused on optimizing existing protein drugs. Aerovance is a Berkeley, Calif.-based company that is focused on the development and commercialization of biologics for respiratory and inflammatory diseases. Interlink Healthcare Communications has undertaken a new assignment for Enzon Pharmaceuticals, as agency of record for Oncaspar, which treats acute lymphoblastic leukemia (also called acute lymphocytic leukemia or ALL), the most common form of cancer in children. The agency will handle promotional communications, primarily directed toward sales force-driven promotion; creative execution for journal ads, direct-to-physician communications, and possibly patient and advocacy communications.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.